Singapore markets closed

Telesis Bio, Inc. (TBIO)

NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
0.3184-0.0129 (-3.89%)
At close: 04:00PM EDT
0.3252 +0.01 (+2.14%)
After hours: 07:03PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 9.58M
Enterprise value 54.11M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.35
Price/book (mrq)40.27
Enterprise value/revenue 1.97
Enterprise value/EBITDA -1.34

Trading information

Stock price history

Beta (5Y monthly) 1.92
52-week change 3-87.58%
S&P500 52-week change 322.36%
52-week high 33.0100
52-week low 30.3000
50-day moving average 30.4519
200-day moving average 30.7298

Share statistics

Avg vol (3-month) 3749.42k
Avg vol (10-day) 393.08k
Shares outstanding 530.1M
Implied shares outstanding 630.1M
Float 89.1M
% held by insiders 137.68%
% held by institutions 137.03%
Shares short (15 Apr 2024) 4105.05k
Short ratio (15 Apr 2024) 41.54
Short % of float (15 Apr 2024) 41.91%
Short % of shares outstanding (15 Apr 2024) 40.35%
Shares short (prior month 15 Mar 2024) 4226.26k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -173.49%
Operating margin (ttm)-87.32%

Management effectiveness

Return on assets (ttm)-28.95%
Return on equity (ttm)-125.42%

Income statement

Revenue (ttm)27.51M
Revenue per share (ttm)0.92
Quarterly revenue growth (yoy)-26.30%
Gross profit (ttm)N/A
EBITDA -32.83M
Net income avi to common (ttm)-49.02M
Diluted EPS (ttm)-1.6400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)19.16M
Total cash per share (mrq)0.64
Total debt (mrq)34.38M
Total debt/equity (mrq)116.39%
Current ratio (mrq)3.71
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-34.67M
Levered free cash flow (ttm)-23.24M